Daiichi Sankyo India Pharma Private Limited, a dissolved (liquidated) private limited company, was established on 13 March 2007 in Gurgaon, Haryana, India. Engaging in book & digital publishing within the media and publishing sector, it holds CIN: U24233HR2007PTC044362. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹178.00 Cr and a paid-up capital of ₹177.00 Cr.
Employing 9 professional, Its leadership includes Masahiko Otsuki (Director), Takashi Mochizuki (Director), Velloor Venkatakrishnan Ranganathan (Director). Past directors included Yoshiyuki Kobayashi, Kiminori Nagao, Kazunori Hirokawa. Its latest AGM occurred on 28 September 2016, with the balance sheet filed on 31 March 2016. It is based at Unit 62, Level 18, One Horizon Center, Golf Course Road, Dlf Phase 5, Sector-4, 3, Gurgaon, Haryana, 122002.
U24233HR2007PTC044362
044362
13 March 2007
₹178.00 Cr
₹177.00 Cr
Roc Delhi
Unlisted
Dissolved (Liquidated)
Explore comprehensive insights into Daiichi Sankyo India Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Masahiko Otsuki | Director | 12 Aug 2010 | Current |
| Takashi Mochizuki | Director | 01 Jul 2017 | Current |
| Velloor Venkatakrishnan Ranganathan | Director | 01 Jul 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 28 Sep 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2012 | Past |
| Pramod Abcsdd | Director | 29 Jul 2011 | Past |
| Pramod Abcsdd | Director | 01 Jul 2017 | Past |
| Pramod Abcsdd | Additional Director | 28 Aug 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Daiichi Sankyo India Pharma Private Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 3.15% increase. The company also saw a slight improvement in profitability, with a 7.27% increase in profit. The company's net worth Soared by an impressive increase of 10.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2016, Daiichi Sankyo India Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Daiichi Sankyo India Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Daiichi Sankyo India Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Daiichi Sankyo India Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Takashi Mochizuki was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 8 years 4 months . was recorded as a recent event.
The activity Velloor Venkatakrishnan Ranganathan was appointed as a Director was appointed as a Director on 01 Jul 2017 & has been associated with this company since 8 years 4 months . was completed.
Daiichi Sankyo India Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2016 as per latest MCA records. was recorded as a recent event.
The activity Daiichi Sankyo India Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Delhi. was completed.
The activity Masahiko Otsuki was appointed as a Director was appointed as a Director on 12 Aug 2010 & has been associated with this company since 15 years 3 months . was completed.
Daiichi Sankyo India Pharma Private Limited was registered on 13 Mar 2007 with Roc Delhi & aged 18 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Daiichi Sankyo India Pharma Private Limited is U24233HR2007PTC044362.
Daiichi Sankyo India Pharma Private Limited is headquartered at Unit 62, Level 18, One Horizon Center, Golf Course Road, Dlf Phase 5, Sector-4, 3, Gurgaon, Haryana, 122002.
Daiichi Sankyo India Pharma Private Limited was incorporated on 13 March 2007.
The current directors of Daiichi Sankyo India Pharma Private Limited are
The primary industry of Daiichi Sankyo India Pharma Private Limited is Media And Publishing.
Daiichi Sankyo India Pharma Private Limited is unlisted.
The authorized capital of Daiichi Sankyo India Pharma Private Limited is ₹178.00 Cr, and the paid-up capital is ₹177.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX